30 April 2020
Visiongain has launched a new pharma report Global Neuromodulation Devices Report 2020-2030: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.
Neuromodulation is one of the fastest growing sectors in the medical devices market for the potential it has as being a relatively non-invasive and cost-effective way of treating debilitating illnesses. This potential remains, yet, unexploited. Growing research into new forms of neuromodulation and the ways it can be applied to different illnesses will drive this market. This is because the techniques not only treat the symptoms of illnesses such as chronic pain, but also provides an effective alternative to drug-based medication that might cause severe side-effects or lead to drug dependence.
The lead analyst of the report commented "Ageing populations in both developed and developing countries and the increasing prevalence of age-related conditions and chronic diseases will drive growth in the neuromodulation devices market. Emerging economies such as China and India will see their neuromodulation devices market increase at a rapid rate during the second half of the forecasted period, due to increased development and research."
Leading companies featured in the report include Medtronic , Boston Scientific , Abbott Laboratories , LivaNova PLC , Stryker Corporation , Nevro Corp. & Other Companies
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
12 January 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
11 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.